This settlement, emerging from a class activity antitrust claim brought In re: Blue Cross Blue Shield Antitrust Litigation MDL 2406, N.D. Ala. Expert File No. 2:13-cv-20000-RDP (the “Settlement”), was reached for people and organizations that bought or got medical coverage gave or managed by a Blue Cross Blue Shield organization. Class Representatives (“Plaintiffs”) arrived at a Settlement on October 16, 2020 with the Blue Cross Blue Shield Association (“BCBSA”) and Settling Individual Blue Plans. BCBSA and Settling Individual Blue Plans are classified “Settling Defendants.”
Offended parties claim that Settling Defendants abused antitrust laws by going into a deal to avoid rivaling one another and to restrict rivalry among themselves in selling medical coverage and authoritative administrations for health care coverage. Settling Defendants deny all charges of bad behavior and state that their direct outcomes in lower medical care costs and more prominent admittance to really focus on their clients. The Court has not concluded who is correct or wrong. All things being equal, Plaintiffs and Settling Defendants have consented to a Settlement to keep away from the danger and cost of additional case.
Whenever endorsed by the Court, the Settlement will set up a $2.67 billion Settlement Fund. Settling Defendants will likewise consent to cause changes in the manner they to work together that Plaintiffs accept will expand the chances for rivalry on the lookout for medical coverage.